Search

This surgeon learned the power of Twitter / Twitter: an ENT surgeon’s perspective

This surgeon learned the power of Twitter I was once Australia’s most followed surgeon on Twitter, according to my dear wife. She was probably right, as always. I had more than 3,700 followers on my account, but very few people...

Young CEORL-HNS: empowering the future of otorhinolaryngology

Young CEORL-HNS is a subgroup within CEORL-HNS which encompasses new specialists in ENT within training and up to the first decade or so as an accredited specialist. Giuditta Mannelli is the current president and is a head and neck surgeon...

Lessons learned from running a national thyroid surgery registry

The UK Registry of Endocrine and Thyroid Surgery is now yielding the rewards of meticulous data collection and years of hard work. David Scott-Coombes discusses the advantages and the unintended consequences of their success. The British Association of Endocrine and...

Hearing aids 2019: today’s technology

High-end or basic hearing aids: does the technology level make a difference? Catherine Palmer shares the current evidence base and suggests where hearing healthcare professionals can make the most impact. The most common complaint from individuals with mild-to-moderately severe hearing...

Using telehealth to engage teenagers

Can we use a teenager’s love of gadgets to re-engage them with their hearing technology? Gwen Carr reports on an innovative use of telehealth to support teenagers who are no longer visiting their hearing healthcare professionals. Parents of children and...

Ronald G Macbeth – the instigator of BACO

The structure of BACO has changed dramatically since the first conference in 1963, but the fundamental elements of academic excellence, instructional sessions and social events have been common threads. Andrew Freeland, who worked with Ronald Macbeth, the instigator of BACO,...

In conversation with the editors of European Archives of ORL-HNS

The journal European Archives of ORL-HNS (EAORL) is a truly pan-European endeavour and has been hugely successful. With an Impact Factor (IF) of 2.6, it is now on a par with Laryngoscope. We spoke to some of the senior editors...

True Cut – a dramatic biopsy from the world of surgery

True Cut is a stage play that asks: “What happens when things go wrong in healthcare?” It brings the hidden world of the operating theatre onto the theatre stage. ENT surgeon, David Alderson, talks about how the play came about....